Current Pharmacogenomics and Personalized Medicine

Aims & Scope

Current Pharmacogenomics and Personalized Medicine (CPPM) is a transdisciplinary, peer-reviewed, biomedical journal that reports new findings and cutting-edge concepts in all areas of pharmacology.

Special consideration is given to articles on pharmacogenomics and personalized medicine.

CPPM is an accelerator for global personalized medicine and pharmacogenomics, as well as preclinical and clinical pharmacology.

Importantly, the journal provides a multi-disciplinary, integrated platform from cell to society to address diagnostics and responsible pharmacogenomics applications in developing countries and the entire range of translational science from bench-to-bedside in various therapeutic areas such as oncology, cardiovascular, neuropharmacology, endocrine diseases, amongst others.

CPPM cooperates with the Ibero-American Network of Pharmacogenetics and the Pacific Rim Association for Clinical Pharmacogenetics and welcomes peer reviewed contributions from authors in any global region.

The journal's scope is defined by four inter-connected aims.

First, we are interested in genomics/postgenomics biotechnologies and diagnostics that enable global personalized medicine science (including and beyond pharmacogenomics), as long as they explain person-to-person and population differences in disease susceptibility or response to a health intervention, and can be substantiated.

Second, we approach personalized medicine as ‘personalized health interventions’ focusing primarily on drug therapy, but also other interventions such as nutrition, vaccines, surgical devices, emerging cell-based therapies that collectively contribute to healthcare.

Third, we strive to integrate molecular and clinical investigation with public policy, global health diplomacy and social studies of biotechnology, that collectively shape postgenomics future(s) and innovation trajectories in life sciences.

View Aims & Scope

---

Metrics & Ranking

SJR (SCImago Journal Rank)

Year	Value
2024	0.123

Quartile

Year	Value
2024	Q4

h-index

Year	Value
2024	23

Journal Rank

Year	Value
2024	27042

Journal Citation Indicator

Year	Value
2024	12

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Embase

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Biochemistry, Genetics and Molecular Biology, Medicine and Pharmacology, Toxicology and Pharmaceutics, designed to support cutting-edge academic discovery.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Activation of CAR and PXR by Dietary, Environmental and Occupational Chemicals Alters Drug Metabolism, Intermediary Metabolism, and Cell Proliferation

  Citation: 119

  Authors: J., L., W.

• The Human Microbiome Project, Personalized Medicine and the Birth of Pharmacomicrobiomics

  Citation: 79

  Authors: Mariam, Rama, Ramy

• Personalizing HER2-Targeted Therapy in Metastatic Breast Cancer Beyond HER2 Status: What We Have Learned from Clinical Specimens

  Citation: 50

  Authors: R., S., T., D.

• Pharmacogenomic Research in South Africa: Lessons Learned and Future Opportunities in the Rainbow Nation

  Citation: 50

  Authors: Louise, Britt, Michael, Collet, Galen

• Targeting Bcl-2 in Herceptin-Resistant Breast Cancer Cell Lines

  Citation: 41

  Authors: Anatasha, Rita

• Alternatively Spliced Genes as Biomarkers for Schizophrenia, Bipolar Disorder and Psychosis: A Blood-Based Spliceome-Profiling Exploratory Study (Supplementry Table)

  Citation: 38

  Authors: S., S., C., G., G., E., T., J., W., I., M.

• The Pathway Less Traveled: Moving from Candidate Genes to Candidate Pathways in the Analysis of Genome-Wide Data from Large Scale Pharmacogenetic Association Studies

  Citation: 37

  Authors: R., R., J.

• A Conceptual Model of Psychoneurological Symptom Cluster Variation in Women with Breast Cancer: Bringing Nursing Research to Personalized Medicine

  Citation: 34

  Authors: Angela, Debra, R., Alison, Yvette, Nancy

• Herbal Drug Discovery: Challenges and Perspectives

  Citation: 33

  Authors: Subramani

• Role of Statistical Random-Effects Linear Models in Personalized Medicine

  Citation: 32

  Authors: Francisco, Hung-Wen, Jose

---